|
Immunotherapy
Citations 61-70 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Increased surveillance of cells in mitosis by human NK cells suggests a novel strategy for limiting tumor growth and viral replication
- Esther N. M. Nolte–'t Hoen, Catarina R. Almeida, Nadia R. Cohen, Shlomo Nedvetzki, Helen Yarwood, and Daniel M. Davis
Blood 2007; 109: 670-673.
[Abstract]
[Full text]
[PDF]
A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?
- Andrew R. Crow, Seng Song, John W. Semple, John Freedman, and Alan H. Lazarus
Blood 2007; 109: 155-158.
[Abstract]
[Full text]
[PDF]
Phospholipase C, calcium, and calmodulin are critical for  4ß1 integrin affinity up-regulation and monocyte arrest triggered by chemoattractants
- Sharon J. Hyduk, Jason R. Chan,, Stewart T. Duffy, Mian Chen, Mark D. Peterson, Thomas K. Waddell, Genevieve C. Digby, Katalin Szaszi, Andras Kapus, and Myron I. Cybulsky
Blood 2007; 109: 176-184.
[Abstract]
[Full text]
[PDF]
The immunosuppressive drug FK778 induces regulatory activity in stimulated human CD4+CD25– T cells
- Ellen Kreijveld, Hans J. P. M. Koenen, Luuk B. Hilbrands, Hans J. P. van Hooff, and Irma Joosten
Blood 2007; 109: 244-252.
[Abstract]
[Full text]
[PDF]
Immune competence of cancer-reactive T cells generated de novo in adult tumor-bearing mice
- Kenneth F. May, Jr, Kenneth Lute, Ergun Kocak, Shahab Abdessalam, Lijie Yin, Ou Li, Zhen Guan, Gary Philips, Pan Zheng, and Yang Liu
Blood 2007; 109: 253-258.
[Abstract]
[Full text]
[PDF]
Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines
- Thomas C. Wehler, Marion Nonn, Britta Brandt, Cedrik M. Britten, Mark Gröne, Mariya Todorova, Irina Link, Shamsul A. Khan, Ralf G. Meyer, Christoph Huber, Udo F. Hartwig, and Wolfgang Herr
Blood 2007; 109: 365-373.
[Abstract]
[Full text]
[PDF]
Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell–depleted reduced-intensity transplantation
- Ralf G. Meyer, Cedrik M. Britten, Daniela Wehler, Klaus Bender, Georg Hess, Abdo Konur, Udo F. Hartwig, Thomas C. Wehler, Andrew J. Ullmann, Chiara Gentilini, Lutz Uharek, Christoph Huber, Karin Kolbe, and Wolfgang Herr
Blood 2007; 109: 374-382.
[Abstract]
[Full text]
[PDF]
Arsenic trioxide: a promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice
- Pierre Bobé, Danielle Bonardelle, Karim Benihoud, Paule Opolon, and Mounira K. Chelbi-Alix
Blood 2006; 108: 3967-3975.
[Abstract]
[Full text]
[PDF]
Optimizing immunotherapy in multiple myeloma: restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells
- Siqing Wang, Sungyoul Hong, Jing Yang, Jianfei Qian, Xiang Zhang, Elizabeth Shpall, Larry W. Kwak, and Qing Yi
Blood 2006; 108: 4071-4077.
[Abstract]
[Full text]
[PDF]
Expression of tumor-associated antigens in acute myeloid leukemia: implications for specific immunotherapeutic approaches
- Jochen Greiner, Michael Schmitt, Li Li, Krzysztof Giannopoulos, Katrin Bosch, Anita Schmitt, Konstanze Dohner, Richard F. Schlenk, Jonathan R. Pollack, Hartmut Dohner, and Lars Bullinger
Blood 2006; 108: 4109-4117.
[Abstract]
[Full text]
[PDF]
|
|
